Medicare Enrolled
Dr. Sam Lerman, MD
Endocrinology · Hollywood, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Lerman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Lerman? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Lerman
Dr. Sam Lerman is an endocrinology in Hollywood, FL, with 19 years in practice. Based on federal Medicare data, Dr. Lerman performed 6,948 Medicare services across 4,121 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lerman received a total of $21,199 from 69 pharmaceutical and/or device companies across 904 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lerman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 10% volume in FL$ $21,199 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,948
Medicare services
Top 10% in FL for endocrinology
4,121
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~366 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) | 731 | $8 | $14 |
| Office visit, established patient (30-39 min) | 681 | $92 | $170 |
| Comprehensive metabolic blood panel | 496 | $10 | $100 |
| Thyroid stimulating hormone (TSH) test | 495 | $16 | $45 |
| Lipid panel (cholesterol and triglycerides) | 443 | $13 | $58 |
| Free thyroxine (T4) test | 441 | $9 | $34 |
| Creatine kinase (cardiac enzyme) level, total | 416 | $6 | $29 |
| Glutamyltransferase (liver enzyme) level | 414 | $7 | $22 |
| Hemoglobin A1c test (diabetes monitoring) | 393 | $10 | $32 |
| Vitamin D level test | 363 | $29 | $150 |
| Thyroid hormone, t3 measurement, total | 290 | $14 | $34 |
| Complete blood count (CBC) with differential | 231 | $8 | $25 |
| Creatinine test (kidney function) | 169 | $5 | $29 |
| Urine microalbumin test (kidney screening) | 159 | $6 | $61 |
| Office visit, established patient (20-29 min) | 138 | $68 | $125 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 136 | $27 | $75 |
| Carbohydrate analysis, single quantitative | 120 | $11 | $85 |
| Basic metabolic blood panel | 101 | $8 | $75 |
| Ultrasound scan of head and neck soft tissue | 88 | $81 | $250 |
| Testosterone (hormone) level, total | 81 | $25 | $75 |
| Sex hormone binding globulin (protein) level | 79 | $21 | $85 |
| Vitamin B-12 level test | 77 | $15 | $80 |
| Parathyroid hormone level test | 71 | $40 | $120 |
| Glycated protein level | 46 | $16 | $40 |
| Automated urinalysis | 43 | $2 | $14 |
| New patient office visit (45-59 min) | 41 | $113 | $350 |
| PSA test (prostate cancer screening) | 39 | $18 | $85 |
| Urine microalbumin (protein) analysis | 24 | $6 | $40 |
| Cortisol (hormone) measurement, total | 22 | $16 | $61 |
| Ldl cholesterol level | 21 | $10 | $29 |
| Prolactin (milk producing hormone) level | 20 | $19 | $53 |
| Office visit, established patient, complex (40-54 min) | 19 | $130 | $230 |
| C-reactive protein test (inflammation marker) | 17 | $5 | $50 |
| Microsomal antibodies (autoantibody) measurement | 15 | $14 | $106 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 15 | $113 | $445 |
| Thyroglobulin (thyroid protein) antibody measurement | 13 | $16 | $85 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$21,199
Total received (2018-2024)
Avg $3,028/year across 7 years
Top 17% in FL for endocrinology
69
Companies
904
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,865 (79.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$4,334 (20.4%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,813
2023$2,441
2022$2,993
2021$2,227
2020$4,112
2019$4,315
2018$3,298
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Tandem Diabetes Care, Inc.
$3,771
Novo Nordisk Inc
$2,264
Lilly USA, LLC
$1,986
SANOFI-AVENTIS U.S. LLC
$1,253
AstraZeneca Pharmaceuticals LP
$1,028
Senseonics, Incorporated
$1,023
Medtronic MiniMed, Inc.
$1,008
Insulet Corporation
$978
Dexcom, Inc.
$660
Amgen Inc.
$484
Xeris Pharmaceuticals, Inc.
$452
Merck Sharp & Dohme Corporation
$452
Mannkind Corporation
$328
Amarin Pharma Inc.
$318
AbbVie, Inc.
$282
Boehringer Ingelheim Pharmaceuticals, Inc.
$263
RECORDATI_RARE_DISEASES_INC.
$259
Antares Pharma, Inc.
$251
Corcept Therapeutics
$238
MannKind Corporation
$234
Amneal Pharmaceuticals LLC
$231
Novartis Pharmaceuticals Corporation
$216
Ascensia Diabetes Care Us Inc.
$215
Abbott Laboratories
$187
IBSA Pharma Inc.
$178
Kowa Pharmaceuticals America, Inc.
$170
Medtronic, Inc.
$156
AbbVie Inc.
$146
Shire North American Group Inc
$141
Janssen Scientific Affairs, LLC
$134
Horizon Therapeutics plc
$127
Neurocrine Biosciences, Inc.
$119
Bayer Healthcare Pharmaceuticals Inc.
$119
Radius Health, Inc.
$118
Ascendis Pharma Inc
$106
ABBVIE INC.
$105
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$95
PFIZER INC.
$82
Bayer HealthCare Pharmaceuticals Inc.
$81
Regeneron Healthcare Solutions, Inc.
$76
GRT US Holding, Inc.
$63
Gemini Laboratories, LLC
$58
DEXCOM, INC.
$55
Alvogen Inc
$54
Kyowa Kirin, Inc.
$50
Orexigen Therapeutics, Inc.
$48
Amryt Pharma Holdings Ltd
$41
Esperion Therapeutics, Inc.
$39
Janssen Pharmaceuticals, Inc
$39
Aytu BioScience, Inc
$37
Rhythm Pharmaceuticals, Inc.
$33
Strongbridge US INC.
$32
Tolmar, Inc.
$30
Ipsen Biopharmaceuticals, Inc
$26
Ascensia Diabetes Care US Inc.
$23
BETA BIONICS, INC.
$21
Clarus Therapeutics Inc.
$20
EUSA Pharma (US) LLC
$20
Astellas Pharma US Inc
$19
Eisai Inc.
$19
Acerus Pharmaceuticals Corporation
$18
Alfasigma USA, Inc.
$16
Currax Pharmaceuticals LLC
$16
Nalpropion Pharmaceuticals LLC
$16
VIVUS, Inc.
$16
CeQur Corporation
$14
Medicure Pharma Inc.
$14
VistaPharm, Inc.
$13
Companion Medical, Inc.
$11
Top 3 companies account for 37.8% of total payments
Associated products mentioned in payments ›
AFREZZA · Androgel · BAQSIMI · BASAGLAR · Belviq · CONTRAVE · CYCLOSET · CeQur Simplicity · Corlanor · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · DIABETES - DISEASE · Dexcom CGM · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SMART TRANSMITTER KIT · Eversense · FARXIGA · FIASP · FREESTYLE LIBRE · FreeStyle Libre · FreeStyle Libre Pro · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · INGREZZA · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · ISTURISA · InPen · JANUVIA · JARDIANCE · JATENZO · Kerendia · Korlym · LEQVIO · LIVALO · LYUMJEV · Levemir · Livalo · MACRILEN · MINIMED 780G · MOUNJARO · MYCAPSSA · Minimed 670G System · Minimed Paradigm Revel · NATPARA · NATPARA (PARATHYROID HORMONE) · NEXLETOL · NEXLIZET · NOCDURNA · Natesto · OTREXUP · Omnipod · Otrexup · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Prolia · QSYMIA · Qutenza · RECORLEV · RYBELSUS · Repatha · Rybelsus · SIGNIFOR LAR · SOLIQUA · SOLIQUA 100/33 · SOMATULINE DEPOT · SOMAVERT · STEGLATRO · SYNTHROID · Saxenda · Sylvant · Synthroid · TEPEZZA · TERIPARATIDE · TOUJEO · TRADJENTA · TRULICITY · TZIELD · Thyquidity · Tirosint · Tymlos · UNITHROID · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XYOSTED · Xultophy 100/3.6 · ZEPBOUND · Zypitamag · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (80%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $305 per 100 Medicare services performed
Geographic Context
Endocrinologys within 10 mi
144
Per 100K population
7.4
County median income
$74,534
Nearest hospital
MEMORIAL REGIONAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lerman is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and high industry engagement (low-engagement, top 17%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lerman experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Lerman performed 731 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Lerman receive payments from pharmaceutical companies?
Yes. Dr. Lerman received a total of $21,199 from 69 companies across 904 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Lerman's costs compare to other endocrinologys in Hollywood?
Dr. Lerman's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Lerman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Endocrinology
Common procedures, typical costs, and what industry payments mean in endocrinology.
Same specialty & city
Endocrinologys in Hollywood
Browse endocrinologys in Hollywood ranked by procedure volume and transparency data.
Highest volume
Top Endocrinologys in FL
Endocrinologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Endocrinologys in FL
Which FL endocrinologys receive the most from drug and device companies.
By company
Tandem Diabetes Care, Inc. Payments to Doctors
See all physicians who received payments from Tandem Diabetes Care, Inc..
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology